Sabin

MD Anderson announces fifth annual class of Andrew Sabin Family Fellows

Retrieved on: 
Thursday, November 12, 2020
University of Texas MD Anderson Cancer Center, University of Texas System, Sabin, Hospitals, Health care, Oncology

HOUSTON, Nov. 12, 2020 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center has named 10 early-career faculty members to the 2020 class of Andrew Sabin Family Fellows.

Key Points: 
  • HOUSTON, Nov. 12, 2020 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center has named 10 early-career faculty members to the 2020 class of Andrew Sabin Family Fellows.
  • Andrew Sabin, of East Hampton, New York, has been a member of the MD Anderson Cancer Center Board of Visitors since 2005.
  • "We are grateful for the generosity of the Andrew Sabin Family Foundation in helping MD Anderson recruit and retain the highest caliber of young researchers through this fellowship program," said Peter WT Pisters, M.D.
  • MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal

Retrieved on: 
Thursday, August 13, 2020
Medical specialties, Polio, Medicine, Albert Sabin, Scientists, Sabin, Gordon Dougan, Albert B. Sabin Gold Medal, Dougan

WASHINGTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.

Key Points: 
  • WASHINGTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.
  • We are pleased to present the Gold Medal to Gordon, said Amy Finan, Sabins chief executive officer.
  • Next, Professor Dougan assembled a world class program for teaching and research at the Wellcome Sanger Institute in Cambridge.
  • View the video highlighting the 2020 Albert B. Sabin Gold Medal and Sabin Rising Star Award, including remarks by Professor Dougan and Dr. Gallagher, as well as their introducers, Dr. Myron M. Levine, University of Maryland School of Medicine, and Dr. Anthony Scott, London School of Hygiene & Tropical Medicine.

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal

Retrieved on: 
Thursday, August 13, 2020
Medical specialties, Polio, Medicine, Albert Sabin, Scientists, Sabin, Gordon Dougan, Albert B. Sabin Gold Medal, Dougan

Washington, D.C., Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.

Key Points: 
  • Washington, D.C., Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.
  • We are pleased to present the Gold Medal to Gordon, said Amy Finan, Sabins chief executive officer.
  • Next, Professor Dougan assembled a world class program for teaching and research at the Wellcome Sanger Institute in Cambridge.
  • View the video highlighting the 2020 Albert B. Sabin Gold Medal and Sabin Rising Star Award, including remarks by Professor Dougan and Dr. Gallagher, as well as their introducers, Dr. Myron M. Levine, University of Maryland School of Medicine, and Dr. Anthony Scott, London School of Hygiene & Tropical Medicine.

First Financial Northwest, Inc. Appoints Ralph C. Sabin to Board of Directors

Retrieved on: 
Tuesday, December 3, 2019
Board of directors, Committees, Corporate law, Corporations, Business, Articles, Audit committee, Auditing, Corporate governance, Sabin

Mr. Sabin is expected to also be appointed to the Board of Directors of the Bank and the Companys non-financial institution subsidiary, First Financial Diversified Corporation (FFD) at their respective meetings to be held later in December.

Key Points: 
  • Mr. Sabin is expected to also be appointed to the Board of Directors of the Bank and the Companys non-financial institution subsidiary, First Financial Diversified Corporation (FFD) at their respective meetings to be held later in December.
  • We are pleased to welcome Mr. Sabin to our Board of Directors, said Joseph W. Kiley III, President and Chief Executive Officer.
  • During his tenure he has represented PVG on the board of directors and audit committees of 15 PVG portfolio companies.
  • Previously, Mr. Sabin was Senior Vice President and Chief Financial Officer of Sonus Pharmaceuticals from 1994 to 1995.

Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees

Retrieved on: 
Thursday, October 17, 2019
Medical specialties, Medicine, Vaccination, Vaccine, Virology, Sabin, Immunology, Polio, RTT, Vaccines

Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its Board of Trustees.

Key Points: 
  • Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its Board of Trustees.
  • The Sabin Vaccine Institute is completing an important transformation, including new leadership among its Trustees and a more ambitious vaccine R&D strategy.
  • Filips extensive experience in clinical development aligns with this direction and makes him well positioned to elevate Sabins work in vaccine R&D, said Dr. Axel Hoos, chair of the Sabin Board of Trustees.
  • The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.

Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth

Retrieved on: 
Tuesday, August 13, 2019
Medical specialties, Vaccination, Sabin Vaccine Institute, Vaccine, Sabin, Medicine, Polio

The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees.

Key Points: 
  • The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees.
  • The Board is pleased to welcome our three newest members, said Dr. Axel Hoos, chair of the Sabin Board of Trustees.
  • Her expertise in global health, social and behavioral science and communications will be a meaningful addition to Sabins work in vaccine acceptance, capacity building and advocacy.
  • The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.

Optoma Wins Two "Best Of Show" Awards At InfoComm 2019

Retrieved on: 
Wednesday, June 12, 2019
Sabin, Audiovisual, Terminology, Television, Optoma Corporation

"With progressive new models in both the home theater and commercial categories, Optoma gave us good cause to recognize their achievements at this year's InfoComm," said Rob Sabin, ProjectorCentral editor-in-chief.

Key Points: 
  • "With progressive new models in both the home theater and commercial categories, Optoma gave us good cause to recognize their achievements at this year's InfoComm," said Rob Sabin, ProjectorCentral editor-in-chief.
  • Both products are well-deserving of ProjectorCentral's InfoComm 2019 Best of Show award," added Sabin.
  • Optoma combines cutting-edge technology and innovation to deliver remarkable visual display products designed to connect audiences with engaging video and audio experiences.
  • Optoma Technology is the U.S. headquarters for The Optoma Group, with continental headquarters also in Europe and Asia.

2019 Andrew Sabin Family Fellows share passion for Making Cancer History

Retrieved on: 
Wednesday, May 8, 2019
Sabin, University of Texas MD Anderson Cancer Center, Health

HOUSTON, May 8, 2019 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center has named eight researchers to the fourth annual class of Andrew Sabin Family Fellows.

Key Points: 
  • HOUSTON, May 8, 2019 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center has named eight researchers to the fourth annual class of Andrew Sabin Family Fellows.
  • At a luncheon today, the 2019 fellows had the opportunity to thank their benefactor, Andrew Sabin, a member of the MD Anderson Cancer Center Board of Visitors.
  • Members of the 2016, 2017 and 2018 classes of Sabin Family Fellows and faculty mentors also attended.
  • "I look forward each year to meeting the new class of Sabin Family Fellows and experiencing their enthusiasm for unlocking the mysteries of cancer," said Sabin.

MD Anderson announces 2018 Andrew Sabin Family Fellows

Retrieved on: 
Thursday, June 7, 2018
University of Texas MD Anderson Cancer Center, University of Texas System, Sabin, Monroe Dunaway Anderson, Health, Texas

HOUSTON, June 7, 2018 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center has named eight researchers to the third annual class of Andrew Sabin Family Fellows.

Key Points: 
  • HOUSTON, June 7, 2018 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center has named eight researchers to the third annual class of Andrew Sabin Family Fellows.
  • As part of the Andrew Sabin Family Fellowship Program, each researcher will receive $100,000 in funding over two years.
  • "By generously funding up to eight fellowships each year, the Andrew Sabin Family Foundation nurtures some of the best and brightest young researchers in our collective fight against cancer," said Peter WT Pisters, M.D., president of MD Anderson.
  • Also in attendance were members of the 2016 and 2017 classes of Sabin Family Fellows as well as faculty mentors.

Dr. Paul Offit Receives 2018 Albert B. Sabin Gold Medal

Retrieved on: 
Tuesday, April 24, 2018
Medicine, Vaccination, Health, Poliomyelitis, Paul Offit, Albert Sabin, Albert B. Sabin Gold Medal, Stanley Plotkin, Sabin, Rotavirus vaccine, Albert Kapikian

WASHINGTON, April 24, 2018 /PRNewswire-USNewswire/ --Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal.

Key Points: 
  • WASHINGTON, April 24, 2018 /PRNewswire-USNewswire/ --Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal.
  • "It's an honor to join the distinguished ranks of Albert B. Sabin Gold Medal recipients," said Dr. Offit.
  • The 2018 Albert B. Sabin Gold Medal ceremony will take place at the National Academy of Sciences building in Washington, D.C. Dr. Offit is the fourth Sabin Gold Medal recipient recognized for medical research contributions to rotavirus vaccines, following Stanley Plotkin, M.D.
  • The 2018 Albert B. Sabin Gold Medal ceremony was made possible in part by the Bill & Melinda Gates Foundation.